IADR Abstract Archives

Evaluation of Cytotoxicity of Pharmaceutical Grade Alginates on HeLa Cells

Objective:  To evaluate the cytotoxicity of various pharmaceutical grade sodium alginates with different guluronate/mannuronate residues on the viability of the HeLA cells.

Methods: Listed in the following table, six pharmaceutical grade sodium alginates (FMC Biopolymers) were used in this study. Alginate beads were prepared by extruding 2wt% sodium alginate solutions through a syringe fitted with 25G needle directly into an aqueous solution of 100mM CaCl2.  Alginate beads weighing ~30, 60 and 120mg were placed into each well of a 24-well culture plate containing 30 to 40% confluent monolayers of the HeLA cells. Following 48 hours of incubation, cell viability was evaluated by a standard colorimetric MTT assay.  

Results: Viability data (mean±SD, n=3) for treated cells compared to control (cells without beads) is listed in the following table. Compared to the control group, cell viability was not altered for the cells treated at lower alginate doses. In contrast, groups 5 and 6, cell viability was significantly reduced by 20-40% when exposed to higher doses of alginates, among all groups.

 GROUP

Sodium Alginate

G/M ratio

Viscosity

Cell viability % @ 30mg

 

Cell viability % @ 60mg

 

Cell viability %

@ 120mg

 

1

Protanal LF240D

30-35/65-70

70-150

97.73±0.045

96.5±0.018

61.03±0.075

2

Protanal LF10/60LS

35-45/55-65

20-70

98.06±0.048

86.49±0.021

73.15±0.035

3

Protanal LF120M

35-45/55-65

70-150

88.23±0.03

89.88±0.036

78.13±0.06

4

Protanal LF10/60

65-75/25-35

20-70

109.96±0.046

97.66±0.03

74.44±0.02

5

Protanal LF200S

65-75/25-35

200-400

119.18±0.021

112.72±0.028

91.7±0.045

6

Protanal LFR5/60

65-75/25-35

300-700

102.11±0.032

91.61±0.035

95.83±0.067

 

Conclusions: The viability of HeLA cells was found to be dependent on the amount of the alginate used. Maximum viability was obtained with 30 and 60mg treatments. Over the entire weight range, alginates with high G content displayed better viability.


IADR/AADR/CADR General Session
2011 IADR/AADR/CADR General Session (San Diego, California)
San Diego, California
2011
1472
Pharmacology, Therapeutics, & Toxicology
  • Cabel, Anamaria I.  ( Nova Southeastern University, FT. Lauderdale, FL, USA )
  • Mccarthy, Shannon K.  ( Nova Southeastern University, FT. Lauderdale, FL, USA )
  • Omidian, Hossein  ( Nova Southeastern University, FT. Lauderdale, FL, USA )
  • Stelnicki, Eric J.  ( Nova Southeastern University, FT. Lauderdale, FL, USA )
  • Kandalam, Umadevi  ( Nova Southeastern University, FT. Lauderdale, FL, USA )
  • Poster Session
    Pharmacology, Therapeutics, & Toxicology I
    03/17/2011